Q&A: NPR Morning Edition host Rachel Martin on connecting with listeners December 2, 2016 By Pete Vernon
As sites abandon comments, The Coral Project aims to turn the tide August 23, 2016 By Nausicaa Renner
How NPR balanced privacy, open access in publishing names of 4,000 mustard gas victims November 9, 2015 By Jack Murtha
How public media collaborations are creating opportunities for local reporting July 22, 2014 By Gabriel Rosenberg Local Journalism Centers offer chances to develop expertise–and build something that lasts
In the summer of #yesallwomen, #menpr seeks to join the conversation July 3, 2014 By Gabriel Rosenberg NPR is running a series on "Men in America"
The demise of NPR’s Tell Me More can be traced to member stations June 5, 2014 By Tracie Powell Shows won’t succeed if affiliates won’t run them
The $1,000 pill is popular! So, who pays? April 24, 2014 By Trudy Lieberman Pricey hepatitis C drug Sovaldi "shattered" sales expectations. Reporters need to keep asking the costs and benefits questions.
A drug offers better care for a disease that affect millions. How can it be ‘low value’? March 17, 2014 By Trudy Lieberman By costing $1,000 a pill. The new hepatitis C treatment puts drug costs on the media agenda
Must-reads of the week February 7, 2014 By The Editors Philip Seymour Hoffman, Ezra Klein, Andrew Rosenthal
The new hepatitis C drug costs how much?! January 2, 2014 By Trudy Lieberman NPR’s Richard Knox gets its right the second time around on high pharmaceutical prices
